Genetech and FDA informed healthcare professionals and asthmatic patients that the prescribing information for Xolair was revised to include a new BOXED WARNING, and updated WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections that address the risk of anaphylaxis (the onset of action can be delayed for 24 hours or more) when taking this … [Read more...]
Another Moistureplus Contact Solution Recall
- Click here for our original post regarding the MoisturePlus contact solution recall from November, 2006 -Advanced Medical Optics (AMO) has issued a voluntary recall on all Complete MoisturePlus contact lens solutions after information received today from the US Centers for Disease Control and Prevention (CDC) revealed so far that 46 patients with … [Read more...]
Avandia Heart Atacks Link- Drug for Diabetics May Increase Risk by 40 Percent
The US Food and Drug Administration issued a safety alert for Avandia, a widely prescribed drug to treat type-2 diabetics. According to FDA, Studies show that there is "a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia." By "potentially significant" they are referring to the 30% - 40% … [Read more...]
FDA Warns Doctors About Gadolinium-Based Contrast Agents
Today FDA warned doctors about gadolinium-based contrast agents used in magnetic resonance imaging (MRI). Some of the companies that provide gadolinium-based MRI dyes to radiologists include: Magnevist, MultiHance, ProHance, Omniscan, and OptiMARK.FDA has requested the companies above to provide new warnings to doctors about the risk of nephrogenic … [Read more...]
FDA Says Purdue Frederick Misrepresented OxyContin Illegally
The US Food and Drug Administration (FDA) announced results today of the investigation into the illegal promotion of OxyContin by The Purdue Frederick Company, makers of the widely abused, highly addictive pain pill."An investigation by OCI uncovered an extensive, long-term conspiracy by The Purdue Frederick Company, Inc. to generate the maximum … [Read more...]
Recent Comments